Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yonglong Pan

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Transplantation Proceedings|October 2, 2022
α-Connexin Carboxyl Terminal Peptide 1 Attenuates Ischemia-Reperfusion Injury in Liver Transplantation With Extended Cold Preservation by Stabilizing Cell Junctions in MiceYuefan Wang, Biao Lei, Yonglong Pan, et al.
Molecular Cancer|February 25, 2025
Cancer stem cells and niches: challenges in immunotherapy resistanceYonglong Pan, Chaoyi Yuan, Chenglong Zeng, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 17, 2022
LINC01608 activated by YY1 facilitate hepatocellular carcinoma progression by modulating the EGFR/ERK axisMengzhen Han, Furong Liu, Xinxin Li, et al.
Genetics|January 16, 2014
Global genomic diversity of Oryza sativa varieties revealed by comparative physical mappingXiaoming Wang, David A Kudrna, Yonglong Pan, et al.
Nature Communications|October 10, 2025
VRK2 targeting potentiates anti-PD-1 immunotherapy in hepatocellular carcinoma through MYC destabilizationChen Su, Zhibin Liao, Jie Mo, et al.
Current Microbiology|April 19, 2017
Isolation of Viable but Non-culturable Bacteria from Printing and Dyeing Wastewater Bioreactor Based on Resuscitation Promoting FactorYi Jin, Guojuan Gan, Xiaoyun Yu, et al.
Experimental Hematology & Oncology|June 9, 2020
Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinomaFurong Liu, Lu Qin, Zhibin Liao, et al.
Cellular Signalling|October 24, 2025
Distal-less homeobox 5 transactivated by MYCN contributes to progression of neuroblastoma through AKT signaling pathwayYi He, Xiaosi Yu, Chenzhao Feng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 12, 2026
SU056 potentiates SULF2 antibody in suppressing cholangiocarcinoma metastasis via SULF2-YBX1-CXCR4 signaling axisMengzhen Han, Yonglong Pan, Xinxin Li, et al.
Medcomm|July 2, 2024
CREB3 suppresses hepatocellular carcinoma progression by depressing AKT signaling through competitively binding with insulin receptor and transcriptionally activating RNA-binding motif protein 38Yi He, Shenqi Han, Han Li, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Transplantation Proceedings|October 2, 2022
α-Connexin Carboxyl Terminal Peptide 1 Attenuates Ischemia-Reperfusion Injury in Liver Transplantation With Extended Cold Preservation by Stabilizing Cell Junctions in MiceYuefan Wang, Biao Lei, Yonglong Pan, et al.
Molecular Cancer|February 25, 2025
Cancer stem cells and niches: challenges in immunotherapy resistanceYonglong Pan, Chaoyi Yuan, Chenglong Zeng, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 17, 2022
LINC01608 activated by YY1 facilitate hepatocellular carcinoma progression by modulating the EGFR/ERK axisMengzhen Han, Furong Liu, Xinxin Li, et al.
Genetics|January 16, 2014
Global genomic diversity of Oryza sativa varieties revealed by comparative physical mappingXiaoming Wang, David A Kudrna, Yonglong Pan, et al.
Nature Communications|October 10, 2025
VRK2 targeting potentiates anti-PD-1 immunotherapy in hepatocellular carcinoma through MYC destabilizationChen Su, Zhibin Liao, Jie Mo, et al.
Current Microbiology|April 19, 2017
Isolation of Viable but Non-culturable Bacteria from Printing and Dyeing Wastewater Bioreactor Based on Resuscitation Promoting FactorYi Jin, Guojuan Gan, Xiaoyun Yu, et al.
Experimental Hematology & Oncology|June 9, 2020
Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinomaFurong Liu, Lu Qin, Zhibin Liao, et al.
Cellular Signalling|October 24, 2025
Distal-less homeobox 5 transactivated by MYCN contributes to progression of neuroblastoma through AKT signaling pathwayYi He, Xiaosi Yu, Chenzhao Feng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 12, 2026
SU056 potentiates SULF2 antibody in suppressing cholangiocarcinoma metastasis via SULF2-YBX1-CXCR4 signaling axisMengzhen Han, Yonglong Pan, Xinxin Li, et al.
Medcomm|July 2, 2024
CREB3 suppresses hepatocellular carcinoma progression by depressing AKT signaling through competitively binding with insulin receptor and transcriptionally activating RNA-binding motif protein 38Yi He, Shenqi Han, Han Li, et al.
Pageof 4